Phase 2B Study of PTC124 (Ataluren) in Duchenne/Becker Muscular Dystrophy (DMD/BMD)

NCT00592553 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

174

Enrollment

INDUSTRY

Sponsor class

Conditions

Duchenne Muscular Dystrophy
Becker Muscular Dystrophy

Interventions

DRUG: Ataluren
DRUG: Placebo

Sponsor

PTC Therapeutics